IMPELLA® or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
Guillaume Schurtz(Inserm), Gilles Lemesle(Centre Hospitalier Universitaire de Lille), Vincent Balmette(Centre Hospitalier Universitaire de Lille), Nicolas Lamblin(Inserm), Ouriel Saura(Sorbonne Université), Flavien Vincent(Centre Hospitalier Universitaire de Lille), Éric Van Belle, Alessandro Cosenza(Centre Hospitalier Universitaire de Lille), Laurent Bonello(Assistance Publique Hôpitaux de Marseille), Natacha Rousse(Inserm), Mouhamed Djahoum Moussa(Inserm), André Vincentelli, Emmanuel Robin(Université de Lille), Sina Porouchani(Centre Hospitalier Universitaire de Lille), Clément Delmas(Université Toulouse III - Paul Sabatier), Basile Verdier(Centre Hospitalier Universitaire de Lille), Nadia Aïssaoui(Université Paris Cité), Françis Juthier, Cédric Delhaye(Valve (United States)), Étienne Puymirat(Inserm)
Cited by 17
Related Papers
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
Randomized Multicenter Comparison of Conventional Anticoagulation Versus Antiplatelet Therapy in Unplanned and Elective Coronary Stenting
|Circulation|1998|583
Acute Myocardial Infarction
|Circulation|2017|534
A Pre-Hospital Extracorporeal Cardio Pulmonary Resuscitation (ECPR) strategy for treatment of refractory out hospital cardiac arrest: An observational study and propensity analysis
|Resuscitation|2017|373
Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock
|Intensive Care Medicine|2011|356